Melanie Keller

Melanie Keller has extensive work experience in the medical and research field. Melanie began their career in 1995 as a Clinical Monitor at Ecron Acunova, where they worked until 1996. In 2005, they joined GPC Biotech/Aggenix as a Clinical Research Associate I, a role they held until 2008. Following this, they worked at vivoPharm Pty Ltd, where they held various positions including Project Manager Europe & US East from 2008 to 2011, Team Leader, Business Unit vivoPharm Europe from 2011 to 2015, and later Division Head vivoPharm Europe Limited from 2015 onwards.

Most recently, Melanie Keller joined Cancer Genetics, Inc. in 2017 as the Division Head Europe. Overall, their work experience spans over two decades, demonstrating their expertise and dedication in the medical and research field.

Melanie Keller completed their Dipl. Biol. degree in Pharmaceutical Biology at the University of Konstanz from 1994 to 2001. Following this, they pursued further education at Ludwig-Maximilians-Universität München, from 2002 to 2005, where they obtained a Dr. rer. nat degree in the Department of Pharmacy.